1. Home
  2. DSP vs PROF Comparison

DSP vs PROF Comparison

Compare DSP & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Viant Technology Inc.

DSP

Viant Technology Inc.

HOLD

Current Price

$11.09

Market Cap

213.3M

Sector

Technology

ML Signal

HOLD

Logo Profound Medical Corp.

PROF

Profound Medical Corp.

HOLD

Current Price

$6.92

Market Cap

243.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DSP
PROF
Founded
1999
N/A
Country
United States
Canada
Employees
N/A
N/A
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
213.3M
243.2M
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
DSP
PROF
Price
$11.09
$6.92
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
1
Target Price
$17.81
$12.00
AVG Volume (30 Days)
224.0K
66.8K
Earning Date
05-11-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
157.14
25.89
EPS
N/A
0.19
Revenue
$344,201,000.00
$16,098,000.00
Revenue This Year
$20.27
$92.40
Revenue Next Year
$16.88
$64.10
P/E Ratio
N/A
$36.61
Revenue Growth
19.00
50.73
52 Week Low
$8.11
$3.92
52 Week High
$15.18
$8.95

Technical Indicators

Market Signals
Indicator
DSP
PROF
Relative Strength Index (RSI) 53.04 49.50
Support Level $11.09 $5.81
Resistance Level $12.61 $7.07
Average True Range (ATR) 0.87 0.42
MACD 0.00 -0.05
Stochastic Oscillator 61.85 19.09

Price Performance

Historical Comparison
DSP
PROF

About DSP Viant Technology Inc.

Viant Technology Inc is an advertising software company. The software enables the programmatic purchase of advertising, which is the electronification of the advertising buying process. It operates a cloud-based demand side platform ("DSP") that is used by marketers and its advertising agencies to centralize the planning, buying and measurement of its advertising across channels, including connected TV (CTV), streaming audio, digital out-of-home, mobile and desktop.

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.

Share on Social Networks: